These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6423926)

  • 1. [Use of thioctic acid for prevention of the adverse effects induced by benznidazole in patients with chronic Chagas' infection].
    Carpintero DJ
    Medicina (B Aires); 1983; 43(3):285-90. PubMed ID: 6423926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Chagas disease with benznidazole and thioctic acid].
    Roldán EJ
    Medicina (B Aires); 2005; 65(1):85-6; author reply 86-7. PubMed ID: 15830800
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thioctic acid in the prevention of the toxic effects of benznidazole].
    Pérez Lloret A; Roldán EJ
    Medicina (B Aires); 1984; 44(1):108. PubMed ID: 6443012
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side-effects of Ro 7-1051, a nitroimidazole used tentatively as a specific treatment for Chagas' disease].
    Levi GC; Amato Neto V; de Araújo Bezerra Sant'anna IF
    Rev Inst Med Trop Sao Paulo; 1975; 17(1):49-52. PubMed ID: 804715
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of Chagas disease with benznidazole and thioctic acid].
    Sosa-Estani S; Armenti A; Araujo G; Viotti R; Lococo B; Ruiz Vera B; Vigliano C; de Rissio AM; Segura EL
    Medicina (B Aires); 2004; 64(1):1-6. PubMed ID: 15034949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tolerance to benzonidazole during the etiological treatment of Chagas' disease].
    de Arruda Júnior ER
    Arq Bras Cardiol; 1987 Jun; 48(6):395-7. PubMed ID: 3128252
    [No Abstract]   [Full Text] [Related]  

  • 7. [Allopurinol in the treatment of chronic Chagas' disease].
    Meirovich CI; Montrull HL; Gallerano RH; Sosa RR
    Arq Bras Cardiol; 1985 Sep; 45(3):217-23. PubMed ID: 3939099
    [No Abstract]   [Full Text] [Related]  

  • 8. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Longitudinal study of the persistence of the therapeutic action of nifurtimox and benznidazole in patients with chronic chagas infection].
    Schenone H; Rojas A; Alfaro E; Concha L; Aranda R
    Bol Chil Parasitol; 1981; 36(3-4):59-62. PubMed ID: 6812600
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).
    Marin-Neto JA; Rassi A; Morillo CA; Avezum A; Connolly SJ; Sosa-Estani S; Rosas F; Yusuf S;
    Am Heart J; 2008 Jul; 156(1):37-43. PubMed ID: 18585495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should benznidazole be used in chronic Chagas' disease?
    Bestetti RB
    Lancet; 1997 Mar; 349(9052):653. PubMed ID: 9057760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-therapeutic trial with benzonidazole in Chagas' disease].
    Ferreira HD
    Rev Inst Med Trop Sao Paulo; 1976; 18(5):357-64. PubMed ID: 827007
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events after the use of benznidazole in infants and children with Chagas disease.
    Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
    Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
    Bocchi EA; Higuchi ML; Vieira ML; Stolf N; Bellotti G; Fiorelli A; Uip D; Jatene A; Pileggi F
    J Heart Lung Transplant; 1998 Apr; 17(4):399-405. PubMed ID: 9588585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythema multiforme due to benzonidazole, in the treatment of Chagas' disease].
    Amato Neto V; Nicodemo AC; de Almeida Neto E
    Rev Inst Med Trop Sao Paulo; 1980; 22(2):93-5. PubMed ID: 6776616
    [No Abstract]   [Full Text] [Related]  

  • 16. Long term evaluation of etiological treatment of chagas disease with benznidazole.
    Cancado JR
    Rev Inst Med Trop Sao Paulo; 2002; 44(1):29-37. PubMed ID: 11896410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
    Moya PR; Trombotto GT
    Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance of benznidazole in a United States Chagas Disease clinic.
    Miller DA; Hernandez S; Rodriguez De Armas L; Eells SJ; Traina MM; Miller LG; Meymandi SK
    Clin Infect Dis; 2015 Apr; 60(8):1237-40. PubMed ID: 25601454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of benznidazole use in the treatment of chronic Chagas' disease.
    Hasslocher-Moreno AM; do Brasil PE; de Sousa AS; Xavier SS; Chambela MC; Sperandio da Silva GM
    J Antimicrob Chemother; 2012 May; 67(5):1261-6. PubMed ID: 22331592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart rate variability in chronic Chagas patients before and after treatment with benznidazole.
    Oliveira LF; Silva VJ; Lages-Silva E; Molina RJ; Fuzissaki J; Niederhaur S; Prata A; Correia D
    Auton Neurosci; 2010 Dec; 158(1-2):118-22. PubMed ID: 20558113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.